Symptom Management of Lung Cancer

Nancy G. Houlihan

Dana Inzeo

Margaret M. Joyce

Leslie B. Tyson

CJON 2004, 8(6), 645-652. DOI: 10.1188/04.CJON.645-652

This chapter excerpt from the book Site-Specific Cancer Series: Lung Cancer, edited by Nancy G. Houlihan, RN, MA, AOCN®, is part of a series of clinically relevant reprints that will appear periodically in the Clinical Journal of Oncology Nursing.

Jump to a section

    References

    Allard, P., Lamontagne, C., Bernard, P., & Tremblay, C. (1999). How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. Journal of Pain and Symptom Management, 17, 256-265.

    American Thoracic Society. (1999). Dyspnea mechanisms, assessment and management: A consensus statement. American Journal of Respiratory and Critical Care Medicine, 159, 321-340.

    Beckles, M.A., Spiro, S.G., Colice, G.L., & Rudd, R.M. (2003). Initial evaluation of the patient with lung cancer. Symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest, 123(Suppl. 1), 97S-104S.

    Beers, M.H., & Berkow, R. (Eds.). (1999). The Merck manual, centennial edition. Whitehouse Station, NJ: Merck Research Laboratories.

    Birn, C.S., & Kosco, P. (2004). Flexible scopes and photodynamic therapy [Continuing education program]. Nursing Spectrum. Retrieved January 14, 2004, from http://nsweb.nursing-spectrum.com/ce/ce264.htm

    Bruera, E., deStoutz, N., Velasco-Leiva, A., Schoeller, T., & Hanson, J. (1993). Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet, 342(8862), 13-14.

    Bruera, E., & Ripamonti, C. (1998). Dyspnea in patients with advanced cancer. In A. Berger, R.K. Portenoy, & D.E. Weissman (Eds.), Principles and practice of supportive oncology (pp. 295-308). Philadelphia: Lippincott Williams & Wilkins.

    Carrieri, V.K., & Janson-Bjerklie, S. (1986). Dyspnea. In V.K. Carrieri, A. Lindsey, & C.M. West (Eds.), Pathophysiologic phenomena in nursing human responses to illness (pp. 191-218). Philadelphia: W.B. Saunders.

    Carrieri-Kohlman, V., Gormley, J.M., Douglas, M.K., Paul, S.M., & Stulbarg, M.S. (1996). Differentiation between dyspnea and its affective components. Western Journal of Nursing Research, 18, 626-642.

    Chetta, A., Gerra, G., Foresi, A., Zaimovic, A., DelDonno, M., Chittolini, B., et al. (1998). Personality profiles and breathlessness measurement in outpatients with different grading of asthma. American Journal of Respiratory and Critical Care Medicine, 157, 116-122.

    Cioffi, D. (1991). Beyond attentional strategies: A cognitive-perceptual model of somatic interpretation. Psychological Bulletin, 109, 25-41.

    Corey, R., & Hla, K.M. (1987). Major and massive hemoptysis: Reassessment of conservative management. American Journal of Medical Science, 294, 301-309.

    Doona, M., & Walsh, D. (1998). Benzonatate for opioids-resistant cough in advanced cancer. Palliative Medicine, 12, 55-58.

    Dudgeon, D.J. (2002). Managing dyspnea and cough. Hematology/Oncology Clinics of North America, 16, 557-577.

    Dudgeon, D.J., Kristjanson, L., Sloan, J.A., Lertzman, M., & Clement, K. (2001). Dyspnea in cancer patients: Prevalence and associated factors. Journal of Pain and Symptom Management, 21(2), 95-102.

    Dudley, D.L., Martin, C.J., & Holmes T.H. (1964). Psychophysiologic studies of pulmonary ventilation. Psychosomatic Medicine, 26, 645-659.

    Dumon, J.F., Shapshay, S., & Bourcerau, J. (1984). Principles for safety in application of neodymium-YAG laser in bronchology. Chest, 86, 163-168.

    Geffin, B., Shapshay, S.M., & Bellack, G.S. (1980). Flammability of endotracheal tubes during ND-YAG laser application in the airway. Anesthesiology, 89, 124-128.

    Gift, A. (1991). Psychologic and physiologic aspects of acute dyspnea in asthmatics. Nursing Research, 40, 196-199.

    Guimarães, C.A. (2002). Massive hemoptysis. In F.G. Pearson, J.D. Cooper, J. Deslauriers, R.J. Ginsberg, C.A. Hiebert, G.A. Patterson, et al. (Eds.), Thoracic surgery (2nd ed., pp. 717-736). New York: Churchill Livingstone.

    Henke, C.S. (2000). Hemoptysis. In D. Camp-Sorrell & R.A. Hawkins (Eds.), Clinical manual for the oncology advanced practice nurse (pp. 137-140). Pittsburgh, PA: Oncology Nursing Society.

    Hetzel, M.R., & Smith, S.G. (1991). Endoscopic palliation of tracheobronchial malignancies. Thorax, 46, 325-333.

    Hirshberg, B., Biran, I., Glazer, M., & Kramer, M. (1997). Hemoptysis: Etiology, evaluation, and outcome in a tertiary referral hospital. Chest, 112, 440-444.

    Hollen, P., Gralla, R., Kris, M., Eberly, S., & Potanovich, L. (1993). Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS). European Journal of Cancer,29A(Suppl. 1), S51-S58.

    Ingle, R.J. (2000). Lung cancers. In C.H. Yarbro, M.H., Frogge, M. Goodman, & S.L. Groenwald (Eds.), Cancer nursing: Principles and practice (5th ed., pp. 1298-1328). Sudbury, MA: Jones and Bartlett.

    Irwin, R.S., Boulet, L.P., Cloutier, M.M., Fuller, R., Gold, P.M., Hoffstein, V., et al. (1998). Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest, 114(Suppl. 2), 133S-181S.

    Jennings, A.L., Davies, A.N., Higgins, J.P., Gibbs, J.S., & Broadley, K.E. (2002). A systematic review of the use of opioids in the management of dyspnea. Thorax, 57, 939-944.

    Joyce, M., McSweeney, M., Carrieri-Kohlman, V.L., & Hawkins, J. (2004). Evidence synthesis: The use of nebulized opioids in the management of dyspnea. Oncology Nursing Forum, 31, 551-561.

    Kvale, P.A., Simoff, M., & Prakash, U.B.S. (2003). Palliative care. Chest, 123(Suppl. 1), 284S-311S.

    McDermott, M.K. (2000). Cough. In D. Camp-Sorrell & R.A. Hawkins (Eds.), Clinical manual for the oncology advanced practice nurse (pp. 127-130). Pittsburgh: Oncology Nursing Society.

    Morice, R.C., Ece, T., Ece, F., & Keus, L. (2001). Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest, 119, 781-787.

    Muers, M.F., & Round, C.E. (1993). Palliation of symptoms in non-small lung cancer: A study by the Yorkshire Regional Cancer Organization thoracic group. Thorax, 48, 339-343.

    Prakash, U.B.S. (1999). Advances in broncho-scopic procedures. Chest, 116, 1403-1408.

    Ripamonti, C., & Fusco, F. (2002). Respiratory problems in supportive care. Cancer, 10, 204-216.

    Shepherd, S., & Geraci, S. (1999). The differential diagnosis of dyspnea: A pathophysiologic approach. Clinician Reviews, 9(4), 52-72.

    Smith, E.L., Hann, D.M., Ahles, T.A., Fursten-berg, C.T., Mitchell, T.A., Meyer, L., et al. (2001). Dyspnea, anxiety, body consciousness and quality of life in patients with lung cancer. Journal of Pain and Symptom Management, 21, 323-329.

    Tanaka, K., Akechi, T., Okuyama, T., Nishiwaki, Y., & Uchitomi, Y. (2001). Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. Journal of Pain and Symptom Management, 23, 484-489.